John Thero, Amarin CEO (Christopher Goodney/Bloomberg via Getty Images)

Amarin los­es patent ap­peal and their brief grip on a car­dio­vas­cu­lar, fish oil em­pire

Amarin’s briefly-held fish oil em­pire has slipped from its grasp, and now ap­pears gone for good.

A US fed­er­al ap­peals court re­fused on Thurs­day to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.